They also stated that they see CLIA labs as their primary route to market. It seems that regardless of FDA approval, this is where they see most of the diagnostics occurring. So I don't see FDA approval as being very important. It seems more of a nice to have to me.
Ann: CPT PLA reimbursement code approved in US for PromarkerD, page-10
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
88.0¢ |
Change
-0.020(2.22%) |
Mkt cap ! $115.1M | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 91.0¢ | 86.5¢ | $99.60K | 112.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8000 | 87.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 89.0¢ | 16900 | 1 |
View Market Depth
| Last trade - 15.54pm 28/06/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |